Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Castel

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Genes, Chromosomes & Cancer|February 15, 2011
Alternative lengthening of telomeres--an enhanced chromosomal instability in aggressive non-MYCN amplified and telomere elongated neuroblastomasGisela Lundberg, Daniel Sehic, John-Kalle Länsberg, et al.
International Journal of Molecular Sciences|September 28, 2021
Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?Gladys G Olivera, Andrea Urtasun, Luis Sendra, et al.
Journal of Personalized Medicine|April 30, 2021
Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric SarcomasAntonio Juan Ribelles, Pablo Gargallo, Pablo Berlanga, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Pharmacogenetics implementation in the clinics: information and guidelines for germline variantsGladys Olivera, Luis Sendra, María José Herrero, et al.
Pediatric Blood & Cancer|February 3, 2009
(123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trialTerry A Vik, Thomas Pfluger, Richard Kadota, et al.
Molecular Oncology|November 30, 2020
Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targetsEsther Coronado, Yania Yañez, Enrique Vidal, et al.
Scientific Reports|February 2, 2020
Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S StagesAntonio Juan Ribelles, Sandra Barberá, Yania Yáñez, et al.
Scientific Reports|September 26, 2019
Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S StagesAntonio Juan Ribelles, Sandra Barberá, Yania Yáñez, et al.
Clinical Epigenetics|March 14, 2015
Two independent epigenetic biomarkers predict survival in neuroblastomaYania Yáñez, Elena Grau, Virginia C Rodríguez-Cortez, et al.
Blood|October 24, 2002
Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remissionFranco Locatelli, Myriam Labopin, Juan Ortega, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Genes, Chromosomes & Cancer|February 15, 2011
Alternative lengthening of telomeres--an enhanced chromosomal instability in aggressive non-MYCN amplified and telomere elongated neuroblastomasGisela Lundberg, Daniel Sehic, John-Kalle Länsberg, et al.
International Journal of Molecular Sciences|September 28, 2021
Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?Gladys G Olivera, Andrea Urtasun, Luis Sendra, et al.
Journal of Personalized Medicine|April 30, 2021
Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric SarcomasAntonio Juan Ribelles, Pablo Gargallo, Pablo Berlanga, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Pharmacogenetics implementation in the clinics: information and guidelines for germline variantsGladys Olivera, Luis Sendra, María José Herrero, et al.
Pediatric Blood & Cancer|February 3, 2009
(123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trialTerry A Vik, Thomas Pfluger, Richard Kadota, et al.
Molecular Oncology|November 30, 2020
Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targetsEsther Coronado, Yania Yañez, Enrique Vidal, et al.
Scientific Reports|February 2, 2020
Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S StagesAntonio Juan Ribelles, Sandra Barberá, Yania Yáñez, et al.
Scientific Reports|September 26, 2019
Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S StagesAntonio Juan Ribelles, Sandra Barberá, Yania Yáñez, et al.
Clinical Epigenetics|March 14, 2015
Two independent epigenetic biomarkers predict survival in neuroblastomaYania Yáñez, Elena Grau, Virginia C Rodríguez-Cortez, et al.
Blood|October 24, 2002
Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remissionFranco Locatelli, Myriam Labopin, Juan Ortega, et al.
Pageof 8